| . "Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.." BMC Med Res Methodol. 2016;16(1):122. Pub Med |
| . "More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines.." Brain Struct Funct. 2014;219(2):551-69. Pub Med |
| . "FMEM: Functional mixed effects modeling for the analysis of longitudinal white matter Tract data.." Neuroimage. 2014;84():753-64. Pub Med |
| . "Longitudinal regression analysis of spatial-temporal growth patterns of geometrical diffusion measures in early postnatal brain development with diffusion tensor imaging.." Neuroimage. 2011;58(4):993-1005. Pub Med |
| . "Multivariate longitudinal shape analysis of human lateral ventricles during the first twenty-four months of life.." PLoS One. 2014;9(9):e108306. Pub Med |
| . "Assessing combinability of phylogenomic data using Bayes factors.." Syst Biol. 2019;68(5):744-754. Pub Med |
| . "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma.." Cancer Discov. 2017;7(10):1116-1135. Pub Med |
| . "Marginal hazard regression for correlated failure time data with auxiliary covariates.." Lifetime Data Anal. 2012;18(1):116-38. Pub Med |
| . "Identifying individual risk rare variants using protein structure guided local tests (POINT).." PLoS Comput Biol. 2019;15(2):e1006722. Pub Med |
| . "Bayesian inference for multivariate meta-analysis Box-Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs.." Stat Med. 2013;32(23):3972-90. Pub Med |
| . "Bayesian inference for network meta-regression using multivariate random effects with applications to cholesterol lowering drugs.." Biostatistics. 2019;20(3):499-516. Pub Med |
| . "Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs.." Stat Med. 2012;31(28):3597-616. Pub Med |
| . "Bayesian inference for multivariate meta-analysis Box-Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs.." Stat Med. 2013;32(23):3972-90. Pub Med |
| . "Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development.." Mol Cell. 2017;67(6):1037-1048.e6. Pub Med |
| . "Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development.." Mol Cell. 2017;67(6):1037-1048.e6. Pub Med |
| . "Mapping eQTL by leveraging multiple tissues and DNA methylation.." BMC Bioinformatics. 2017;18(1):455. Pub Med |
| . "Alignment and mapping methodology influence transcript abundance estimation.." Genome Biol. 2020;21(1):239. Pub Med |
| . "Studying gene and gene-environment effects of uncommon and common variants on continuous traits: a marker-set approach using gene-trait similarity regression.." Am J Hum Genet. 2011;89(2):277-88. Pub Med |
| . "Multivariate phenotype association analysis by marker-set kernel machine regression.." Genet Epidemiol. 2012;36(7):686-95. Pub Med |
| . "A framework for understanding cancer comparative effectiveness research data needs.." J Clin Epidemiol. 2012;65(11):1150-8. Pub Med |
| . "Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.." Stat Med. 2018;37(9):1407-1418. Pub Med |
| . "LIBERTI: A SMART study in plastic surgery.." Clin Trials. 2018;15(3):286-293. Pub Med |
| . "Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs.." Nat Commun. 2019;10(1):309. Pub Med |
| . "Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.." Stat Med. 2014;33(27):4715-33. Pub Med |
| . "PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.." Sci Transl Med. 2016;8(369):369ra175. Pub Med |
| . "SMAC: Spatial multi-category angle-based classifier for high-dimensional neuroimaging data.." Neuroimage. 2018;175():230-245. Pub Med |
| . "Assessing combinability of phylogenomic data using Bayes factors.." Syst Biol. 2019;68(5):744-754. Pub Med |
| . "Estimating Bayesian phylogenetic information content. ." Syst Biol. 2016;65(6):1009-1023. Pub Med |
| . "A precision medicine approach to develop and internally validate optimal exercise and weight loss treatments for overweight and obese adults with knee osteoarthritis.." Arthritis Care Res (Hoboken). 2021;73(5):693-701. Pub Med |
| . "A precision medicine approach to develop and internally validate optimal exercise and weight loss treatments for overweight and obese adults with knee osteoarthritis.." Arthritis Care Res (Hoboken). 2021;73(5):693-701. Pub Med |
| . "Characterizing expected benefits of biomarkers in treatment selection.." Biostatistics. 2015;16(2):383-99. Pub Med |
| . "Biomarker threshold adaptive designs for survival endpoints.." J Biopharm Stat. 2018;28(6):1038-1054. Pub Med |
| . "A model-based conditional power assessment for decision making in randomized controlled trial studies. ." Stat Med. 2017;36(30):4765-4776. Pub Med |
| . "Set-valued dynamic treatment regimes for competing outcomes.." Biometrics. 2014;70(1):53-61. Pub Med |
| . "Using decision lists to construct interpretable and parsimonious treatment regimes.." Biometrics. 2015;71(4):895-904. Pub Med |
| . "Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.." Stat Med. 2018;37(26):3776-3788. Pub Med |
| . "Robust regression for optimal individualized treatment rules.." Stat Med. 2019;38(11):2059-2073. Pub Med |
| . "Stratified Fisher's exact test and its sample size calculation.." Biom J. 2014;56(1):129-40. Pub Med |
| . "Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.." Biometrics. 2020;76(2):630-642. Pub Med |
| . "Testing and estimation in marker-set association study using semiparametric quantile regression kernel machine.." Biometrics. 2016;72(2):364-71. Pub Med |
| . "A robust method for estimating optimal treatment regimes.." Biometrics. 2012;68(4):1010-8. Pub Med |
| . "Response to reader reaction.." Biometrics. 2015;71(1):267-273. Pub Med |
| . "Set-valued dynamic treatment regimes for competing outcomes.." Biometrics. 2014;70(1):53-61. Pub Med |
| . "Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.." Biometrics. 2014;70(4):1003-13. Pub Med |
| . "Bayesian design of noninferiority trials for medical devices using historical data.." Biometrics. 2011;67(3):1163-70. Pub Med |
| . "Efficient methods for signal detection from correlated adverse events in clinical trials.." Biometrics. 2019;75(3):1000-1008. Pub Med |
| . "Using decision lists to construct interpretable and parsimonious treatment regimes.." Biometrics. 2015;71(4):895-904. Pub Med |
| . "Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.." Biometrics. 2011;67(4):1422-33. Pub Med |
| . "Bayesian clinical trial design using historical data that inform the treatment effect.." Biostatistics. 2019;20(3):400-415. Pub Med |
| . "Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690.." BMC Med Res Methodol. 2012;12():183. Pub Med |
